Research facility · founded 1983
Beckman Research Institute
- Citations, last 5 years
- 43.4k
- Works, last 5 years
- 2 597
- h-index
- 528
- Scientists listed
- 0
- Grants since 2016
- 719
Grants received
2022–2024 · career development · K99
Immune Evasion Mechanisms of KSHV Complement and Fc-Receptor Proteins
Murali Bagalur Muniraju · Beckman Research Institute · funded by National Institutes of Health
2022–2027 · research · R01
Phase 1 Evaluation of Enhanced Natural Killer Cells as a Treatment Strategy in Non-Small cell Lung Cancer Patients Refractory to PD-1/PD-L1 Immune Checkpoint Inhibitors
Miguel A Villalona · Beckman Research Institute · funded by National Institutes of Health
2022–2025 · research · R21
Targeting MUC16 transactivation for ovarian cancer treatment
Edward Wenge Wang · Beckman Research Institute · funded by National Institutes of Health
2022–2026 · research · R01
Role of de novo pyrimidine biosynthesis in pathological cardiac remodeling
Zhao Wang · Beckman Research Institute · funded by National Institutes of Health
2022–2023 · award
Mechanical states are emergent properties of biology underlying cancer risk
Stefan Hinz · Beckman Research Institute · funded by American Cancer Society
2022–2025 · award
Wearable biosensors for point of care personalization of cancer drugs
Wei Gao · Beckman Research Institute · funded by American Cancer Society
2022–2024 · research · R21
Modeling and Targeting B/Myeloid Mixed Phenotype Acute Leukemia
Wenyong Chen · Beckman Research Institute · funded by National Institutes of Health
2022–2026 · research · R01
An integrated toolkit combining computational systems biology techniques with molecular dynamics simulations to delineate functionality of GPCRs
Andrei Rodin · Beckman Research Institute · funded by National Institutes of Health
2022–2026 · research · R01
Extracellular Vesicle-mediated islet immune cross talk in Type 1 Diabetes pathogenesis
Sally Choate Kent · Beckman Research Institute · funded by National Institutes of Health
2022 · research · Research
Comparing Two Ways To Improve Physical Function in Older Adults After Lung Cancer Surgery
Dan Raz · Beckman Research Institute · funded by Patient-Centered Outcomes Research Institute
2022 · program · P30
Genomic and Microenvironment Analysis of HIV-Associated Diffuse Large B-cell Lymphoma (Immuno/Microenvironment)
Steven Terry Rosen · Beckman Research Institute · funded by National Institutes of Health
2022–2025 · research · R21
Development of Family1st-An interactive web-based tool with evidence-based approaches to communicate hereditary cancer risk to at risk relatives and promote cascade testing.
Stacy W. Gray · Beckman Research Institute · funded by National Institutes of Health
2022–2027 · research · Established Investigator Award
Novel mechanisms of cardio-metabolic disease: Role of inter-organ crosstalk
Zhao Wang · Beckman Research Institute · funded by American Heart Association
2022–2024 · research · R21
Genomic Analysis of Cutaneous CD30+ Lymphoproliferative Disorders
Christiane Querfeld · Beckman Research Institute · funded by National Institutes of Health
2022–2024 · research · R21
Modeling and Targeting B/Myeloid Mixed Phenotype Acute Leukemia
Wenyong Chen · Beckman Research Institute · funded by National Institutes of Health
2022–2027 · research · R01
Leveraging Digital Health Solutions to Reduce Learning and Functional Disparities in Children with Cancer
Sunita K Patel · Beckman Research Institute · funded by National Institutes of Health
2022–2027 · research · R01
Integration of epidemiology, pathology, immunology and outcomes in colorectal cancer
Stephen B Gruber · Beckman Research Institute · funded by National Institutes of Health
2022 · research · Lustgarten Foundation-AACR Pancreatic Cancer Career Development Award, in Honor of John Robert Lewis
Targeting Macropinocytosis as a Novel Avenue for Pancreatic Cancer Therapy
Edwin R. Manuel · Beckman Research Institute · funded by American Association for Cancer Research
2022 · research · ASH Bridge Grant
ASH Bridge Grant 2022: Nadia Carlesso
Nadia Carlesso · Beckman Research Institute · funded by American Society of Hematology
2022–2025 · grant · DP5
Biomarkers, mechanisms and modulation of oxidative stress associated risk factors in carcinogenesis
Yun Rose Li · Beckman Research Institute · funded by National Institutes of Health
2022–2025 · research · R01
Mechanism and therapeutic opportunities of targeting the Tudor domain
Chun-Wei David Chen · Beckman Research Institute · funded by National Institutes of Health
2022–2026 · research · R01
The Role of miR-142 in the Transformation of Clonal Hematopoietic Disorders into AML
Guido Marcucci · Beckman Research Institute · funded by National Institutes of Health
2022–2027 · research · R01
Integration of epidemiology, pathology, immunology and outcomes in colorectal cancer
Stephen B Gruber · Beckman Research Institute · funded by National Institutes of Health
2022–2027 · research · R01
The role of YTHDC1 in normal and malignant hematopoiesis
Zhijian Qian · Beckman Research Institute · funded by National Institutes of Health
2022–2027 · research · R01
Leveraging Digital Health Solutions to Reduce Learning and Functional Disparities in Children with Cancer
Sunita K Patel · Beckman Research Institute · funded by National Institutes of Health
2022–2027 · research · R01
Microbial- based targeting of major extracellular matrix components for improved therapy of pancreatic cancer
Edwin Manuel · Beckman Research Institute · funded by National Institutes of Health
2022–2027 · research · R01
Extracellular Vesicle-mediated islet immune cross talk in Type 1 Diabetes pathogenesis
Sally Choate Kent · Beckman Research Institute · funded by National Institutes of Health
2022–2027 · research · R01
The role and therapeutic potential of IGF2BP2 in MLL-rearranged leukemia
Jianjun Chen · Beckman Research Institute · funded by National Institutes of Health
2022–2027 · grant · DP5
Biomarkers, mechanisms and modulation of oxidative stress associated risk factors in carcinogenesis
Yun Rose Li · Beckman Research Institute · funded by National Institutes of Health
2022–2027 · research · R01
Randomized Trial of Exercise Therapy on Markers of Progression in Localized Prostate Cancer
Paul Christopher Boutros · Beckman Research Institute · funded by National Institutes of Health
2021–2025 · fellowship · F31
Impact of RNA splicing factor mutations on circular RNA biogenesis in leukemia
Mike Fernandez · Beckman Research Institute · funded by National Institutes of Health
2021–2026 · research · R01
Targeting tumor-associated macrophages for triple-negative breast cancer treatment
Mingye Feng · Beckman Research Institute · funded by National Institutes of Health
2021–2026 · research · R01
Overcoming ibrutinib resistance in mantle cell lymphoma
Alexey V. Danilov · Beckman Research Institute · funded by National Institutes of Health
2021–2026 · research · R50
Improving Outcomes for Multiple Myeloma Patients through Novel Therapeutic Interventions
Enrico Caserta · Beckman Research Institute · funded by National Institutes of Health
2021–2023 · research · R01
Retinoic Acid Induced Lymphangiogenesis for Post-surgical Lymphedema
Alex K. Wong · Beckman Research Institute · funded by National Institutes of Health
2021–2023 · research · R21
Effects of tumor-microbial interactions on EGFR-targeted therapy resistance in lung cancer
Dan J Raz · Beckman Research Institute · funded by National Institutes of Health
2021–2026 · research · R01
Elucidating the role of DNAPKcs in chromosomal break end joining and clastogen resistance
Jeremy Michael Stark · Beckman Research Institute · funded by National Institutes of Health
2021–2026 · research · R01
Repurposing Leflunomide to Delay Progression of Smoldering Multiple Myeloma in African Americans
Flavia Pichiorri · Beckman Research Institute · funded by National Institutes of Health
2021–2026 · research · R01
KSHV Subunit Vaccine Candidates to Elicit Potent Humoral Immune Reponses against KSHV Infection
Javier Gordon Ogembo · Beckman Research Institute · funded by National Institutes of Health
2021–2026 · research · R01
Overcoming ibrutinib resistance in mantle cell lymphoma
Alexey V. Danilov · Beckman Research Institute · funded by National Institutes of Health